Clarus Therapeutics Expands Board of Directors with Appointment of Two Pharmaceutical Industry Veterans

NORTHBROOK, Ill. – July 21, 2014 – Clarus Therapeutics, Inc., a men’s health…


Clarus Therapeutics Presents Phase 3 Data for REXTORO® for Men with Hypogonadism

Results presented at ICE/ENDO 2014, the world’s largest meeting on…


Clarus Therapeutics Secures $31.5 Million in Financing

Announces New Appointment to Board of Directors NORTHBROOK, Ill. – June 12,…


Clarus Therapeutics to Present Phase 3 Data for REXTORO(R) at ICE/ENDO 2014

Poster Presentations to Highlight Safety, Efficacy and Dosing Data for Clarus'…


Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer

Company Adds Pharmaceutical Veteran with Nearly 30 Year Sales and Marketing…


Clarus Therapeutics Presents at 32nd Annual J.P. Morgan Healthcare Conference

NORTHBROOK, Ill – January 9, 2014 -- Clarus Therapeutics, Inc., today announced…


Clarus Therapeutics Bolsters Executive Team with Addition of Chief Medical and Chief Scientific Officers

NORTHBROOK, Ill – July 1, 2013 -- Clarus Therapeutics, Inc., today announced…